U.S. Markets closed

Teva Pharmaceutical Industries Limited (TEVA)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
32.61+0.09 (+0.28%)
At close: 4:02PM EDT
People also watch
MYLGILDNVSAMGNABT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue21,903,00019,652,00020,272,000
Cost of Revenue10,044,0008,296,0009,216,000
Gross Profit11,859,00011,356,00011,056,000
Operating Expenses
Research Development2,111,0001,525,0001,488,000
Selling General and Administrative5,096,0004,717,0005,078,000
Non Recurring2,498,0001,762,000539,000
Others---
Total Operating Expenses---
Operating Income or Loss2,154,0003,352,0003,951,000
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes2,154,0003,352,0003,951,000
Interest Expense1,330,0001,000,000313,000
Income Before Tax824,0002,352,0003,638,000
Income Tax Expense521,000634,000591,000
Minority Interest1,656,000158,00042,000
Net Income From Continuing Ops329,0001,588,0003,055,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income329,0001,588,0003,055,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares68,0001,573,0003,055,000